Autopsy report · NCT03397186

Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Administrative”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 2
Sponsor: Fred Hutchinson Cancer Center
Sponsor type: University, hospital or other
Conditions: Myxoid Liposarcoma; Round Cell Liposarcoma; Stage III Soft Tissue Sarcoma AJCC v7; Stage IV Soft Tissue Sarcoma AJCC v7; Metastatic Soft Tissue Sarcoma; Unresectable Soft Tissue Sarcoma
Interventions: Biopsy; Laboratory Biomarker Analysis; Trabectedin
Participants: 0
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.